Pharmacokinetics of P-glycoprotein inhibition in the rat blood-brain barrier.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Pharmacy and Science

• Publication date

  2008-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/jps.21359PMID 18384156
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evaluation of Tracer Kinetic Models for Quantification of P-Glycoprotein Function using (R)-[11C]Verapamil and PET

  2007cited by this paper
• Pharmacokinetic Consequences of Active Drug Efflux at the Blood–Brain Barrier

  2006cited by this paper
• Verapamil P-glycoprotein Transport across the Rat Blood-Brain Barrier: Cyclosporine, a Concentration Inhibition Analysis, and Comparison with Human Data

  2006cited by this paper
• Duration and degree of cyclosporin induced P-glycoprotein inhibition in the rat blood-brain barrier can be studied with PET

  2006cited by this paper
• In Vivo Evaluation of P-glycoprotein Function at the Blood-Brain Barrier in Nonhuman Primates Using [11C]Verapamil

  2006cited by this paper
• Imaging P‐glycoprotein Transport Activity at the Human Blood‐brain Barrier with Positron Emission Tomography

  2005cited by this paper
• Variable modulation of opioid brain uptake by P-glycoprotein in mice.

  2004cited by this paper
• Quantitative assessment of P-glycoprotein function in the rat blood-brain barrier by distribution volume of [11C]verapamil measured with PET

  2003cited by this paper
• Radioligand studies: imaging and quantitative analysis.

  2002cited by this paper
• Cesium effect: high chemoselectivity in direct N-alkylation of amines.

  2002cited by this paper
• Fully automated high yield synthesis of (R)‐ and (S)‐[11C]verapamil for measuring P‐glycoprotein function with positron emission tomography

  2002cited by this paper
• Brain uptake and receptor binding of two [11C]labelled selective high affinity NK1-antagonists, GR203040 and GR205171--PET studies in rhesus monkey.

  2000cited by this paper
• Enzyme-catalysed improved resolution of (RS)-4-cyano-4-(3,4-dimethoxyphenyl)-4-isopropyl-1-butanol

  1999cited by this paper
• Design, synthesis, and in vitro activity of catamphiphilic reverters of multidrug resistance: discovery of a selective, highly efficacious chemosensitizer with potency in the nanomolar range.

  1999cited by this paper
• A new in vivo method to study P-glycoprotein transport in tumors and the blood-brain barrier.

  1999influential reference
• Rationale for influx enhancement versus efflux blockade to increase drug exposure to the brain

  1998cited by this paper
• The effect of verapamil on the transport of peptides across the blood-brain barrier in rats: kinetic evidence for an apically polarized efflux mechanism.

  1995cited by this paper
• Fluorescent cellular indicators are extruded by the multidrug resistance protein.

  1993cited by this paper
• Comparison of four basic models of indirect pharmacodynamic responses

  1993cited by this paper
• Is the multidrug transporter a flippase?

  1992cited by this paper
• P-glycoprotein as the drug efflux pump in primary cultured bovine brain capillary endothelial cells.

  1992cited by this paper
• Photosensitized labeling of a functional multidrug transporter in living drug-resistant tumor cells.

  1990cited by this paper
• Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.

  1989cited by this paper

• Tramadol Effects on Lameness Score After Inhibition of P-GP by Ivermectin Administration in Horses: Preliminary Results.

  2020cites this paper
• Pharmacokinetic Modeling of the Impact of P-glycoprotein on Ondansetron Disposition in the Central Nervous System

  2020cites this paper
• P-Glycoprotein Efflux Transporters and Its Resistance Its Inhibitors and Therapeutic Aspects

  2020cites this paper
• Treatment Strategies for Dravet Syndrome

  2018cites this paper
• Plasma Glycoprotein Efflux Induced Resistance: Implications, Mechanism, Inhibitors, and Novel Strategies to Overcome

  2018cites this paper
• Clinical Applications of Simultaneous PET/MR Imaging Using (R)-[11C]-Verapamil with Cyclosporin A: Preliminary Results on a Surrogate Marker of Drug-Resistant Epilepsy

  2016cites this paper
• Importance of P-gp PET Imaging in Pharmacology.

  2016cites this paper
• Species Differences and Impact of Disease State on BBB

  2015cites this paper
• Drug Discovery Methods for Studying Brain Drug Delivery and Distribution

  2014cites this paper
• [¹⁸F]Altanserin and small animal PET: impact of multidrug efflux transporters on ligand brain uptake and subsequent quantification of 5-HT₂A receptor densities in the rat brain.

  2014cites this paper
• Confounding parameters in preclinical assessment of blood-brain barrier permeation: an overview with emphasis on species differences and effect of disease states.

  2013cites this paper
• Small and Innovative Molecules as New Strategy to Revert MDR

  2013cites this paper
• Advances in PET imaging of P-glycoprotein function at the blood-brain barrier.

  2013cites this paper
• Role of CNS efflux drug transporters in antiepileptic drug delivery: overcoming CNS efflux drug transport.

  2012cites this paper
• Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy 165 In Vivo Active Drug Uptake and Efflux at the Blood-Brain Barrier With Focus on Drug Transport Interactions

  2012cites this paper
• Pharmacoresistance.

  2012cites this paper
• Comparison of human, mouse and rat ABC transporters on basis of their substrate and inhibitor profile

  2012cites this paper
• Pharmacokinetic modeling of P-glycoprotein function at the rat and human blood–brain barriers studied with (R)-[11C]verapamil positron emission tomography

  2012cites this paper
• Synthesis and preclinical evaluation of [11C]D617, a metabolite of (R)-[11C]verapamil.

  2012cites this paper
• (R)-[11C]Verapamil PET studies to assess changes in P-glycoprotein expression and functionality in rat blood-brain barrier after exposure to kainate-induced status epilepticus

  2011cites this paper
• Inhibitory effects of furanocoumarin derivatives in Kampo extract medicines on P-glycoprotein at the blood-brain barrier.

  2011cites this paper
• Modulation and absorption of xenobiotics: the synergistic role of CYP450 and P-gp activities in cancer and neurodegenerative disorders.

  2011cites this paper
• Blood-brain barrier P-glycoprotein function in neurodegenerative disease.

  2011cites this paper
• Verapamil PET studies to assess changes in P-glycoprotein expression and functionality in rat blood-brain barrier after exposure to kainate-induced status epilepticus

  2010cites this paper
• Substrates, inhibitors and activators of P-glycoprotein: candidates for radiolabeling and imaging perspectives.

  2010cites this paper
• Imaging of P‐glycoprotein–mediated pharmacoresistance in the hippocampus: Proof‐of‐concept in a chronic rat model of temporal lobe epilepsy

  2010influential citation
• Transporterhypothese der Pharmakoresistenz von Epilepsien

  2010cites this paper
• 11C-verapamil to assess P-gp function in human brain during aging, depression and neurodegenerative disease.

  2010cites this paper
• Modulating P‐glycoprotein regulation: Future perspectives for pharmacoresistant epilepsies?

  2010cites this paper
• Using PET studies of P-gp function to elucidate mechanisms underlying the disposition of drugs.

  2010cites this paper
• Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy.

  2009cites this paper
• The Challenge of Pain Management in Patients With Myasthenia Gravis

  2009cites this paper
• Methodologies to assess brain drug delivery in lead optimization.

  2009cites this paper
• Addition of verapamil in the treatment of severe myoclonic epilepsy in infancy.

  2009cites this paper
• Species Differences in Blood-Brain Barrier Transport of Three Positron Emission Tomography Radioligands with Emphasis on P-Glycoprotein Transport

  2009cites this paper
• Transdermal Drug Delivery by Microneedles: Does Skin Metabolism Matter?

  2009cites this paper
• Design and evaluation of novel PET and SPECT tracers for imaging the monoamine system and the P-gp transporter

  2009cites this paper
• Development of a surrogate marker for P-glycoprotein expression in drug-resistant epilepsy using the (R)-[

  2008cites this paper
• Species differences in blood-brain barrier transport of three PET radioligands with emphasis on P-glycoprotein transport

  2008cites this paper
• of Drug-Resistant Epilepsy Preliminary Results on a Surrogate Marker C]-Verapamil with Cyclosporin A: 11 )-[ R PET/MR Imaging Using ( Clinical Applications of Simultaneous

  year unknowncites this paper